Gastrointestinal Cancer News

The FDA approved a new cetuximab dosage regimen for the treatment of patients with KRAS wild-type, EGFR-expressing colorectal cancer or squamous cell carcinoma of the head and neck, according to a press release.

The diagnostic yield of pancreatic ductal adenocarcinoma was substantial in high-risk mutation carrier but non-existent in mutation-negative proven familial pancreatic cancer kindreds.

The FDA granted breakthrough therapy designation to futibatinib for the treatment of patients with locally advanced or metastatic cholangiocarcinoma with FGFR2 gene rearrangements, according to a press release from the agent’s manufacturer.

The FDA cleared an investigational new drug application for the combination of AFM24 and SNK-01 in patients with solid tumors that express epidermal growth factor receptor, according to a joint press release from each agent’s manufacturer.

Major risk factors for CVD were associated with elevated risk for colorectal cancer, according to research published in EClinicalMedicine.

The FDA approved pembrolizumab in combination with platinum- and fluoropyrimidine-based chemotherapy for patients with locally advanced or metastatic esophageal or gastroesophageal carcinoma.

Cancer clinical trial participants living in poorer neighborhoods had worse OS, PFS and cancer-specific survival than those from affluent areas, according to results of a retrospective study published in Journal of Clinical Oncology.

CV risk factors such as age, sex, smoking status, 10-year atherosclerotic CVD risk and certain biomarkers were independently associated with risk for future cancer, according to data published in JACC: CardioOncology.

In this episode, Shikha Jain, MD, goes from being the interviewer to interviewee as she discusses her path to medicine, the importance of good mentorship, and how social media could shape the future of medicine.

The odds of readmission for acute MI or major bleeding after PCI were greater among patients with cancer compared with those with no cancer, with the likelihood varying by cancer type and presence of metastasis, researchers reported.